Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The Avenir Award Program for Research on Substance Abuse and HIV/AIDS is dedicated to supporting early stage investigators proposing innovative studies at the intersection of substance abuse and HIV/AIDS, in line with NIH HIV/AIDS Research Priorities. The program encourages creative and original research with the potential to significantly impact substance-using populations at risk for or living with HIV/AIDS. It aims to fund projects that could lead to a reduction in HIV incidence, enhancements in therapies for HIV, a decrease in the impact of comorbid conditions, and, ultimately, the eradication of HIV. The connection with drug abuse should be clearly articulated in the proposals.

Eligibility

Organization's Location
sunt pariatur, quis velit, in deserunt, id excepteur, culpa aliqua, ipsum enim
Program Location
reprehenderit ad cillum consectetur incididunt exercitation veniam ut eiusmod nisi
Organization Type
up to 1.5M

Submission

Schedule
Step 1: velit eu id
Application deadline
Nov 13, 2024
Step 2: magna ea (id deserunt)

Similar grants